SpringerLink
Log in

Over-expression of metastasis-associated in colon cancer-1 (MACC1) associates with better prognosis of gastric cancer patients

  • Original Article
  • Published:
Chinese Journal of Cancer Research

Abstract

Objective

The aim of this study was to detect metastasis-associated in colon cancer-1 (MACC1) expression in Chinese gastric cancer and analyze the relationship between MACC1 expression and postoperative survival.

Methods

The expression of MACC1 and c-MET protein in a sample of 128 gastric cancer tissues was detected by immunohistochemistry. A retrospective cohort study on the prognosis was carried out and data were collected from medical records.

Results

The positive rate of MACC1 protein expression in gastric cancer was 47.66%, higher than that in adjacent noncancerous mucosa (P<0.001). MACC1 protein expression was not related to the clinicopathological variables involved. Kaplan-Meier analysis revealed that the survival of MACC1 positive group tended to be better than that of MACC1 negative group, particularly in patients with stage III carcinoma (P=0.032). Cox regression analysis revealed that MACC1 protein over-expression in gastric cancer tended to be a protective factor with hazard ratio of 0.621 (P=0.057). Immunohistochemical analysis showed that the positive rate of c-MET protein expression was much higher in cases with positive MACC1 expression in gastric cancer (P=0.002), but P53 expression was not associated with MACC1 expression.

Conclusion

MACC1 over-expression implies better survival and may be an independent prognostic factor for gastric cancer in Chinese patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Siewert JR, Bottcher K, Stein HJ, et al. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 1998;228:449–461.

    Article  PubMed  CAS  Google Scholar 

  2. Iwanicki-Caron I, Di Fiore F, Roque I, et al. Usefulness of the serum carcinoembryonic antigen kinetic for chemotherapy monitoring in patients with unresectable metastasis of colorectal cancer. J Clin Oncol 2008;26:3681–3686.

    Article  PubMed  Google Scholar 

  3. Ishigami S, Sakamoto A, Uenosono Y, et al. Carcinoembryonic antigen messenger RNA expression in blood can predict relapse in gastric cancer. J Surg Res 2008;148:205–209.

    Article  PubMed  CAS  Google Scholar 

  4. Yamamoto M, Baba H, Toh Y, et al. Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients. J Cancer Res Clin Oncol 2007;133:471–476.

    Article  PubMed  CAS  Google Scholar 

  5. Kim HJ, Lee KW, Kim YJ, et al. Chemotherapy-induced transient CEA and CA19-9 surges in patients with metastatic or recurrent gastric cancer. Acta Oncol 2009;48:385–390.

    Article  PubMed  CAS  Google Scholar 

  6. Takahashi Y, Takeuchi T, Sakamoto J, et al. The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study. Gastric Cancer 2003;6:142–145.

    Article  PubMed  Google Scholar 

  7. Kochi M, Fujii M, Kanamori N, et al. Evaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancer. Gastric Cancer 2000;3:177–186.

    Article  PubMed  Google Scholar 

  8. Ubukata H, Katano M, Motohashi G, et al. Evaluation of CA72-4 as a tumor marker in patients with gastric cancer. Gan To Kagaku Ryoho 2003;30:1821–1824.

    PubMed  Google Scholar 

  9. Sheng SL, Wang Q, Huang G. Development of time-resolved immunofluorometric assays for CA 72-4 and application in sera of patients with gastric tumors. Clin Chim Acta 2007;380:106–111.

    Article  PubMed  CAS  Google Scholar 

  10. Goral V, Yesilbagdan H, Kaplan A, et al. Evaluation of CA 72-4 as a new tumor marker in patients with gastric cancer. Hepatogastroenterology 2007;54:1272–1275.

    PubMed  CAS  Google Scholar 

  11. Fernandes LL, Martins LC, Nagashima CA, et al. CA72-4 antigen levels in serum and peritoneal washing in gastric cancer. Correlation with morphological aspects of neoplasia. Arq Gastroenterol 2007;44:235–239.

    Article  PubMed  Google Scholar 

  12. Ozkan H, Kaya M, Cengiz A. Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer. Hepatogastroenterology 2003;50:1669–1674.

    PubMed  Google Scholar 

  13. Ucar E, Semerci E, Ustun H, et al. Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer. Adv Ther 2008;25:1075–1084.

    Article  PubMed  Google Scholar 

  14. Gao YC, Yuan ZB, Yang YD, et al. Effect of freeze-thaw cycles on serum measurements of AFP, CEA, CA125 and CA19-9. Scand J Clin Lab Invest 2007;67:741–747.

    Article  PubMed  CAS  Google Scholar 

  15. Stein U, Walther W, Arlt F, et al. MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med 2009;15:59–67.

    Article  PubMed  CAS  Google Scholar 

  16. Stein U, Dahlmann M, Walther W. MACC1-more than metastasis? Facts and predictions about a novel gene. J Mol Med 2009;88:11–18.

    Article  PubMed  Google Scholar 

  17. Kokoszynska K, Krynski J, Rychlewski L, et al. Unexpected domain composition of MACC1 links MET signaling and apoptosis. Acta Biochim Pol 2009;56:317–323.

    PubMed  CAS  Google Scholar 

  18. Stein U, Smith J, Walther W, et al. MACC1 controls Met: what a difference a Sp1 site makes. Cell Cycle 2009;8:2467–2469.

    Article  PubMed  CAS  Google Scholar 

  19. Wierstra I. Sp1: emerging roles—beyond constitutive activation of TATA-less housekee** genes. Biochem Biophys Res Commun 2008;372:1–13.

    Article  PubMed  CAS  Google Scholar 

  20. Yuezheng Zhang, Lianhai Zhang, Yang Gao, et al. Discovery and validation prognostic markers in gastric cancer by genome-wide expression profiling. World J Gastroenterol 2010.

  21. American Joint Committee on Cancer: Gastric Cancer. AJCC Cancer Staging. Manual, 2002, 6th ed. pp. 99–103. New York: Springer-Verlag.

    Google Scholar 

  22. Zhang M, Zhang H, Ma Y, et al. Prognosis and surgical treatment of gastric cancer invading adjacent organs. ANZ J Surg 2010;80:510–514.

    Article  PubMed  Google Scholar 

  23. Moghimi-Dehkordi B, Safaee A, Zali M R. Survival rates and prognosis of gastric cancer using an actuarial life-table method. Asian Pac J Cancer Prev 2008;9:317–321.

    PubMed  Google Scholar 

  24. Santoro R, Carboni F, Lepiane P, et al. Clinicopathological features and prognosis of gastric cancer in young European adults. Br J Surg 2007;94:737–742.

    Article  PubMed  CAS  Google Scholar 

  25. Maehara Y, Kakeji Y, Oda S, et al. Time trends of surgical treatment and the prognosis for Japanese patients with gastric cancer. Br J Cancer 2000;83:986–991.

    Article  PubMed  CAS  Google Scholar 

  26. Prat M, Narsimhan RP, Crepaldi T, et al. The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int J Cancer 1991;49:323–328.

    Article  PubMed  CAS  Google Scholar 

  27. Okamoto W, Okamoto I, Yoshida T, et al. Identification of c-Src as a potential therapeutic target for gastric cancer and of MET activation as a cause of resistance to c-Src inhibition. Mol Cancer Ther 2010;9:1188–1197.

    Article  PubMed  CAS  Google Scholar 

  28. Benvenuti S, Comoglio PM. The MET receptor tyrosine kinase in invasion and metastasis. J Cell Physiol 2007;213:316–325.

    Article  PubMed  CAS  Google Scholar 

  29. Shimazaki K, Yoshida K, Hirose Y, et al. Cytokines regulate c-Met expression in cultured astrocytes. Brain Res 2003;962:105–110.

    Article  PubMed  CAS  Google Scholar 

  30. Holgren C, Dougherty U, Edwin F, et al. Sprouty-2 controls c-Met expression and metastatic potential of colon cancer cells: sprouty/c-Met upregulation in human colonic adenocarcinomas. Oncogene 2010;29:5241–5253.

    Article  PubMed  CAS  Google Scholar 

  31. Kuniyasu H, Yasui W, Kitadai Y, et al. Frequent amplification of the c-met gene in scirrhous type stomach cancer. Biochem Biophys Res Commun 1992;189:227–232.

    Article  PubMed  CAS  Google Scholar 

  32. Kaji M, Yonemura Y, Harada S, et al. Participation of c-met in the progression of human gastric cancers: anti-c-met oligo-nucleotides inhibit proliferation or invasiveness of gastric cancer cells. Cancer Gene Ther 1996;3:393–404.

    PubMed  CAS  Google Scholar 

  33. Amemiya H, Kono K, Itakura J, et al. c-Met expression in gastric cancer with liver metastasis. Oncology 2002;63:286–296.

    Article  PubMed  CAS  Google Scholar 

  34. Nakajima M, Sawada H, Yamada Y, et al. The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas. Cancer 1999;85:1894–1902.

    PubMed  CAS  Google Scholar 

  35. Drebber U, Baldus SE, Nolden B, et al. The over-expression of c-met as a prognostic indicator for gastric carcinoma compared to p53 and p21 nuclear accumulation. Oncol Rep 2008;19:1477–1483.

    PubMed  Google Scholar 

  36. Uen YH, Lin SR, Wu CH, et al. Clinical significance of MUC1 and c-Met RT-PCR detection of circulating tumor cells in patients with gastric carcinoma. Clin Chim Acta 2006;367:55–61.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Surgery, Peking University School of Oncology, Bei**g Cancer Hospital & Institute, Bei**g, 100142, China

    Shao-hua Ge, **ao-jiang Wu, **ao-hong Wang, **ao-fang **ng, Lian-hai Zhang, Yu-bing Zhu, Hong Du & Jia-fu Ji

  2. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University School of Oncology, Bei**g Cancer Hospital & Institute, Bei**g, 100142, China

    Bin Dong

  3. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Tissue Bank, Peking University School of Oncology, Bei**g Cancer Hospital & Institute, Bei**g, 100142, China

    Ying Hu

Authors
  1. Shao-hua Ge
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. **ao-jiang Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. **ao-hong Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. **ao-fang **ng
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lian-hai Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yu-bing Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hong Du
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Bin Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ying Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jia-fu Ji
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jia-fu Ji.

Additional information

This work was supported by the grants of the Foundation from Bei**g Municipal Committee of Science and Technology (No. D0905001040631), and the Scientific Research Foundation for the Returned Overseas Chinese Scholars from Ministry of Education of China.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ge, Sh., Wu, Xj., Wang, Xh. et al. Over-expression of metastasis-associated in colon cancer-1 (MACC1) associates with better prognosis of gastric cancer patients. Chin. J. Cancer Res. 23, 153–159 (2011). https://doi.org/10.1007/s11670-011-0153-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11670-011-0153-9

Key words

Search

Navigation